Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Nihonbashi Life Science HUB

25 oct 2018 9:00 a.m. - 26 oct 2018 6:00 p.m.

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

7th DIA Cardiac Safety Workshop in Japan

It will be a unique opportunity to learn of and discuss the current state and future directions of CV risk assessments and how to prepare for a new regulatory paradigm.

[Session 4] Cardiovascular Safety in Oncology Drug Development: Mechanisms of Cardiotoxicity

Session Chair(s)

Katsuyoshi  Chiba, PhD

Katsuyoshi Chiba, PhD

Senior Director and Head, Group III, Medicinal Safety Research Laboratories, R&D

Daiichi Sankyo Co., Ltd., Japan

Atsushi  Sugiyama, MD, PhD

Atsushi Sugiyama, MD, PhD

Professor and Chairman, Department of Pharmacology

Toho University Faculty of Medicine, Japan

Speaker(s)

Atsuhiko T. Naito, MD, PhD

Drug-Induced Cardiac Toxicity: Translating Non-Clinical Observations into Early Clinical Investigation

Atsuhiko T. Naito, MD, PhD

Toho University Faculty of Medicine, Japan

Associate Professor, Department of Pharmacology, School of Medicine

Yasunari  Kanda, PhD

Development and Standardization of in vitro Contractility Method Using Human iPS Cell-Derived Cardiomyocytes

Yasunari Kanda, PhD

National Institute of Health Sciences, Japan

Head of Division of Pharmacology

Junichi  Ishida, MD, PhD

Molecular Pathways and Pathophysiology of TKI Induced Cardiotoxicity

Junichi Ishida, MD, PhD

The University of Tokyo Hospital, Japan

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.